Shockwave Medical Inc (Nasdaq: SWAV) tau pom zoo kom tau Neovasc Inc (Nasdaq: NVCN) rau kev them nyiaj ua ntej ntawm $ 27.25 ib feem, sib xws rau tus nqi lag luam ntawm kwv yees li $ 100 lab.
Qhov kev txiav txim siab nyiaj ntsuab ua ntej sawv cev rau 27% thiab 68% tus nqi them rau tus nqi kaw thiab 30-hnub VWAP, raws li, ntawm Neovasc cov kev sib koom ntawm Lub Ib Hlis 13, 2023.
Neovasc cov tswv lag luam tseem yuav tau txais cov nyiaj them rov qab uas muaj peev xwm ua tau raws li txoj cai tsis muaj txiaj ntsig kev lag luam (CVR), tso cai rau tus tswv kom tau txais nyiaj ntxiv txog $ 12 ib feem ntawm cov nyiaj ntsuab yog tias qee qhov kev tswj hwm tau ua tiav.
Shockwave cia siab tias yuav ua tiav qhov kev sib pauv hauv thawj ib nrab ntawm 2023.
Neovasc's Innovative Reducer System yuav tsom rau kwv yees li $ 5 billion refractory angina lag luam.
Lub Neovasc Reducer System tau tso cai Breakthrough Device tsim los ntawm FDA, tau pom zoo nyob rau hauv European Union, thiab tam sim no tso npe cov neeg mob hauv COSIRA-II txoj kev tshawb fawb los txhawb FDA pom zoo rau coronary obstructive refractory angina.
Raws li qhov tshwm sim, Shockwave Medical tau tshaj tawm ib ntus Q4 FY22 muag ntawm $ 143- $ 144 lab, nce 70% -71%. Q4 FY22 US Coronary cov nyiaj tau los yuav tsum yog $ 81- $ 82 lab.
Kev muag khoom ib ntus rau FY22 tau cia siab tias yuav yog $ 489- $ 490 lab, nce 106% -107%.
Shockwave Medical tej yaam num FY23 cov nyiaj tau los ntawm $660-$680 lab, nce kwv yees li 35%-39% Y/Y.
Nqe Nqis: SWAV shares poob 9.37% ntawm $183.00, thiab NVCN shares tau nce 31.75% ntawm $28.38 thaum lub sij hawm ua ntej kev sib ntsib ntawm daim tshev kawg hnub Tuesday.
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
© 2023 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/shockwave-medical-seeks-bolster-cardiovascular-135042909.html